Loading patent…
AssigneesTeijin Limited, The Chemo-Sero-Therapeutic Research Institute
InventorsSyoji Ono, Yuji Fukumoto, Tsunemasa Yoshida
Estimating the term…
An immunoglobulin composition comprising an immunoglobulin, and as an aggregation preventing agent or an aggregate dissociating agent for the immunoglobulin, about 1 to about 600% by weight, based on the weight of the immunoglobulin, of a water-soluble acid additive salt of a basic nitrogen-containing organic compound containing one or more basic nitrogen atoms in the molecule and optionally carboxyl groups in smaller number than the basic nitrogen atoms and having a pKb at 25.degree. C. of not more than 7; and a method for producing an immunoglobulin composition having a high monomer content, which comprises contacting an immunoglobulin in aqueous solution with about 1 to about 600% by weight, based on the weight of the immunoglobulin, of a water-soluble acid addition salt thereby to prevent aggregation of the monomer of the immunoglobulin, and when the immunoglobulin contains aggregated molecules, dissociating the aggregated molecules into monomers, and thereafter, if desired, lyophilizing the resulting product.
A method for producing a native immunoglobulin composition having a high monomer content, which comprises contacting a native immunoglobulin in aqueous solution with about 10 to about 600% by weight, based on the weight of the native immunoglobulin, of a water-soluble acid addition salt of a basic amino acid having a pKb at 25.degree. C. of not more than 7 at a temperature between about 0.degree. and about 50.degree. C. in the absence of freezing and at a pH between about 5 and about 8, thereby to prevent aggregation of the monomer of the native immunoglobulin in the aqueous solution, and when the native immunoglobulin contains aggregated molecules, dissociating the aggregated molecules in the aqueous solution into monomers.
Dependencies are inferred from the claim text.